Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis. - Elborn JS; Horsley A; MacGregor G; Bilton D; Grosswald R; Ahuja S; Springman EB (Clinical and translational science, 2017)